[go: up one dir, main page]

DE60128945D1 - Verfahren zur abtrennung von extrachromosomaler dns aus einer zellsuspension - Google Patents

Verfahren zur abtrennung von extrachromosomaler dns aus einer zellsuspension

Info

Publication number
DE60128945D1
DE60128945D1 DE60128945T DE60128945T DE60128945D1 DE 60128945 D1 DE60128945 D1 DE 60128945D1 DE 60128945 T DE60128945 T DE 60128945T DE 60128945 T DE60128945 T DE 60128945T DE 60128945 D1 DE60128945 D1 DE 60128945D1
Authority
DE
Germany
Prior art keywords
extracromosomal
cellususpension
dna
separating
separating extracromosomal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128945T
Other languages
English (en)
Other versions
DE60128945T2 (de
Inventor
Henry Charlton
Alex Eon-Duval
Robert Macduff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE60128945D1 publication Critical patent/DE60128945D1/de
Publication of DE60128945T2 publication Critical patent/DE60128945T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60128945T 2000-11-21 2001-11-20 Verfahren zur abtrennung von extrachromosomaler dns aus einer zellsuspension Expired - Lifetime DE60128945T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0028361 2000-11-21
GBGB0028361.4A GB0028361D0 (en) 2000-11-21 2000-11-21 Method of separating extra chromosomal dna from other cellular components
PCT/GB2001/005114 WO2002042317A2 (en) 2000-11-21 2001-11-20 Method of separating extra-chromosomal dna from other cellular components

Publications (2)

Publication Number Publication Date
DE60128945D1 true DE60128945D1 (de) 2007-07-26
DE60128945T2 DE60128945T2 (de) 2008-02-28

Family

ID=9903579

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128945T Expired - Lifetime DE60128945T2 (de) 2000-11-21 2001-11-20 Verfahren zur abtrennung von extrachromosomaler dns aus einer zellsuspension

Country Status (13)

Country Link
US (1) US20040076980A1 (de)
EP (1) EP1335926B1 (de)
JP (1) JP4422406B2 (de)
AR (1) AR031482A1 (de)
AT (1) ATE364613T1 (de)
AU (1) AU2002223841A1 (de)
CA (1) CA2428885A1 (de)
DE (1) DE60128945T2 (de)
ES (1) ES2287189T3 (de)
GB (1) GB0028361D0 (de)
MY (1) MY129812A (de)
TW (1) TWI289142B (de)
WO (1) WO2002042317A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107634D0 (en) * 2001-03-27 2001-05-16 Fermentas Ab Nucleic acid purification
WO2006083721A2 (en) 2005-01-31 2006-08-10 Merck & Co., Inc. Purification process for piasmid dna
US8546127B2 (en) * 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
ES2666559T3 (es) 2009-12-01 2018-05-07 Translate Bio, Inc. Entrega del mrna para la aumentación de proteínas y enzimas en enfermedades genéticas humanas
AT509622A1 (de) * 2010-04-08 2011-10-15 Greiner Bio One Gmbh Verfahren und kit zur trennung viraler und prokaryontischer von eukaryontischen nukleinsäuren
US10597652B2 (en) * 2011-03-29 2020-03-24 Phynexus, Inc. Methods and devices for nucleic acid purification
US11274292B2 (en) 2011-03-29 2022-03-15 Phynexus, Inc. Devices and methods for plasmid purification
US10883100B2 (en) 2011-03-29 2021-01-05 Phynexus, Inc Devices and methods for plasmid purification
BR112013031553A2 (pt) 2011-06-08 2020-11-10 Shire Human Genetic Therapies, Inc. composições, mrna que codifica para uma hgla e seu uso, uso de pelo menos uma molécula de mrna e um veículo de transferência e uso de um mrna que codifica para proteína exógena
EP2859102A4 (de) 2012-06-08 2016-05-11 Shire Human Genetic Therapies Nukleaseresistente polynukleotide und verwendungen davon
US9931417B2 (en) 2012-12-13 2018-04-03 Immunomedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
MX379460B (es) 2012-12-13 2025-03-11 Immunomedics Inc Dosis de inmunoconjugados de anticuerpos y sn-38 para eficacia mejorada y toxicidad reducida.
ES2819573T3 (es) 2012-12-13 2021-04-16 Immunomedics Inc Método para producir inmunoconjugados de anticuerpo-SN-38 con un enlazador CL2A
EP4446413A3 (de) 2013-03-14 2024-12-18 Translate Bio, Inc. Verfahren zur reinigung von messenger-rna
WO2014153052A2 (en) 2013-03-14 2014-09-25 Shire Human Genetic Therapies, Inc. Cftr mrna compositions and related methods and uses
CN105407891A (zh) * 2013-07-23 2016-03-16 免疫医疗公司 具有cl2a接头的抗体-sn-38免疫缀合物
CN105658242A (zh) 2013-10-22 2016-06-08 夏尔人类遗传性治疗公司 用于苯丙酮尿症的mrna疗法
ES2707966T3 (es) 2013-10-22 2019-04-08 Translate Bio Inc Terapia de ARNm para la deficiencia en síntesis de argininosuccinato
CN106164248B (zh) 2014-04-25 2019-10-15 川斯勒佰尔公司 信使rna的纯化方法
ES2960429T3 (es) 2015-05-29 2024-03-04 Curevac Mfg Gmbh Método para producir y purificar ARN, que comprende al menos una etapa de filtración de flujo tangencial
AU2017257254B2 (en) 2016-04-27 2022-02-24 Immunomedics, Inc. Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
MX2019010155A (es) 2017-02-27 2020-12-10 Translate Bio Inc Arnm de cftr optimizado por codón novedoso.
WO2018183041A1 (en) 2017-03-27 2018-10-04 Immunomedics, Inc. Treatment of trop-2 expressing triple negative breast cancer with sacituzumab govitecan and a rad51 inhibitor
US10799597B2 (en) 2017-04-03 2020-10-13 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy
WO2018213476A1 (en) 2017-05-16 2018-11-22 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
KR20210060480A (ko) 2018-08-24 2021-05-26 트랜슬레이트 바이오 인코포레이티드 전령 rna의 정제 방법
CA3120647A1 (en) 2018-11-21 2020-05-28 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr
US20220098574A1 (en) * 2019-01-29 2022-03-31 Flagship Pioneering Innovations V, Inc. Methods of separating long polynucleotides from a composition
CN116790578B (zh) * 2023-08-22 2023-12-12 赛奥斯博生物科技(北京)有限公司 一种基于碱裂解法快速纯化质粒的生产工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561064A (en) * 1994-02-01 1996-10-01 Vical Incorporated Production of pharmaceutical-grade plasmid DNA
KR100318808B1 (ko) * 1996-02-06 2004-05-20 로셰 디아그노스틱스 게엠베하 정제핵산의제조방법및그의용도
US7026468B2 (en) * 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US6011148A (en) * 1996-08-01 2000-01-04 Megabios Corporation Methods for purifying nucleic acids
US7807822B2 (en) * 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
EP0853123A1 (de) * 1997-01-10 1998-07-15 Roche Diagnostics GmbH Reinigung von DNA durch Cross-Flow-Filtration
US6214586B1 (en) * 1997-12-08 2001-04-10 Genzyme Corporation Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
US6268492B1 (en) * 1998-08-10 2001-07-31 Chiron Corporation Methods for purifying non-chromosomal nucleic acid molecules from cells
PL364816A1 (en) * 1999-07-23 2004-12-13 Genentech, Inc. Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration
US6747132B2 (en) * 2000-11-29 2004-06-08 Apex Biosciences, Inc. Methods for the synthesis of a modified hemoglobin solution

Also Published As

Publication number Publication date
AU2002223841A1 (en) 2002-06-03
DE60128945T2 (de) 2008-02-28
CA2428885A1 (en) 2002-05-30
EP1335926A2 (de) 2003-08-20
WO2002042317A2 (en) 2002-05-30
ATE364613T1 (de) 2007-07-15
GB0028361D0 (en) 2001-01-03
JP4422406B2 (ja) 2010-02-24
ES2287189T3 (es) 2007-12-16
JP2004514428A (ja) 2004-05-20
TWI289142B (en) 2007-11-01
US20040076980A1 (en) 2004-04-22
WO2002042317A3 (en) 2003-02-06
AR031482A1 (es) 2003-09-24
MY129812A (en) 2007-05-31
EP1335926B1 (de) 2007-06-13

Similar Documents

Publication Publication Date Title
DE60128945D1 (de) Verfahren zur abtrennung von extrachromosomaler dns aus einer zellsuspension
DE60127386D1 (de) Verfahren zur entfernung von quecksilber aus kohlenwasserstoffen
DE50010474D1 (de) Verfahren zur verkapselung von bauelementen
DE60017751D1 (de) Ein verfahren zur abtrennung von isobuten aus normalen buten-gemischen
DE60134873D1 (de) Verfahren zur abtrennung von polaren verunreinigungen aus aromatischen beschickungen
ATE553259T1 (de) Verfahren zur papierherstellung
ATE268312T1 (de) Verfahren zur entsalzung von meerwasser
DE60143516D1 (de) Verfahren zur trennung einer imidverbindung
ATA14022001A (de) Verfahren zur entnahme einer probe aus einem system
DE60100434D1 (de) Verfahren zur epoxidierung von olefinen
DE50002724D1 (de) Verfahren zur querstromfiltration
ATE273260T1 (de) Verfahren zur trennung von olefinen von gesättigten kohlenwasserstoffen
DE60104073D1 (de) Verfahren zur chromatographischen Trennung
DE60125906D1 (de) Verfahren zur Verbesserung von Leistung
DE50109309D1 (de) Verfahren zur trennung von pentennitril-isomeren
DE50105109D1 (de) Verfahren zur Ermittlung von Netzwerktopologien
EP1353933A4 (de) Verfahren zur reinigung von lactose
DE60024535D1 (de) Verfahren zur Zeichentrennung
DE50013144D1 (de) Verfahren zum Auswählen von Bezeichnungen aus einer vorgegebenen Liste
DE60038171D1 (de) Verfahren zur Auswahl von Übertragungsentitäten
DE60215164D1 (de) Verfahren zur wiedergewinnung von brennbaren bestandteilen aus einem gasstrom
DE60116661D1 (de) Verfahren zur zurückgewinnung von materialien aus bisphenolteer
DE50007212D1 (de) Verfahren zur isolierung von olefinen aus polyolefinanlagen
DE60004315D1 (de) Verfahren zur Entfernung von Bor aus Polyalkylhydroxyaromaten
DE60011151D1 (de) Verfahren zur gastrennung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition